BioHarvest Sciences Inc. Stock price

Equities

BHSC

CA09076J1084

Food Processing

Market Closed - Canadian Securities Exchange 03:13:30 2024-03-28 pm EDT 5-day change 1st Jan Change
0.28 CAD 0.00% Intraday chart for BioHarvest Sciences Inc. -5.08% +30.23%
Sales 2021 2.1M 2.84M Sales 2022 5.5M 7.44M Capitalization 98.54M 133M
Net income 2021 -9M -12.18M Net income 2022 -11M -14.89M EV / Sales 2021 77.8 x
Net cash position 2021 1.46M 1.97M Net Debt 2022 8.82M 11.94M EV / Sales 2022 19.5 x
P/E ratio 2021
-16.1 x
P/E ratio 2022
-8.7 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 67.61%
More Fundamentals * Assessed data
Dynamic Chart
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules MT
BioHarvest Sciences Inc. Announces Launch of New Contract Development and Manufacturing Organization Business Unit CI
BioHarvest Sciences Inc. Signs First Contracts with Two Industrial Customers to Develop Complex Molecules Via Its Newly Launched Botanical Synthesis CDMO Business Unit CI
BioHarvest Sciences Inc. announced that it has received CAD 13.622872 million in funding CI
Bioharvest Sciences Inc. Announces Major Product Launch of Vinia-Based Functional Coffee Products CI
BioHarvest Sciences Inc. Provides Revenue Guidance for the Fourth Quarter 2023 CI
Bioharvest Sciences Inc. Revises Revenue Guidance for the Year 2023 CI
BioHarvest Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
BioHarvest Sciences Inc. announced that it expects to receive CAD 12 million in funding CI
BioHarvest Sciences Inc. Receives Canadian Product License from Health Canada's Natural and Non-Prescription Health Products Directorate CI
BioHarvest Sciences Inc. Provides Revenue Guidance for the Third Quarter of 2023 CI
BioHarvest Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
BioHarvest Sciences Up After Reporting Closing of Private Placement of Convertible Notes MT
BioHarvest Sciences Inc. announced that it has received CAD 4.642076 million in funding CI
BioHarvest Sciences Inc. announced that it expects to receive CAD 4.625103 million in funding CI
More news
1 week-5.08%
Current month+21.74%
1 month+16.67%
3 months+30.23%
6 months+64.71%
Current year+30.23%
More quotes
1 week
0.26
Extreme 0.255
0.30
1 month
0.20
Extreme 0.2
0.30
Current year
0.20
Extreme 0.2
0.30
1 year
0.14
Extreme 0.14
0.30
3 years
0.14
Extreme 0.14
0.54
5 years
0.10
Extreme 0.1
0.71
10 years
0.10
Extreme 0.1
0.71
More quotes
Managers TitleAgeSince
Chief Executive Officer - 20-06-08
Director of Finance/CFO 72 18-10-08
Chairman 66 18-09-26
Members of the board TitleAgeSince
Director/Board Member 57 13-04-18
Chairman 66 18-09-26
Director/Board Member 73 21-10-20
More insiders
Date Price Change Volume
24-03-28 0.28 0.00% 13,000
24-03-27 0.28 +1.82% 80,200
24-03-26 0.275 +1.85% 51,500
24-03-25 0.27 -5.26% 90,527
24-03-22 0.285 0.00% 172,000

Delayed Quote Canadian Securities Exchange, March 28, 2024 at 03:13 pm EDT

More quotes
BioHarvest Sciences Inc. is a Canada-based biotechnology company. The Company offers Botanical Synthesis, its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The Company is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals: as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. The Company operates through two segments: Nutraceuticals and Pharmaceuticals. The Company offers a polyphenol/antioxidant superfruit product called VINIA, which is a red grape powder that supplies the benefits of red wine consumption but without the sugar, calories and alcohol found in wine.
More about the company
  1. Stock
  2. Equities
  3. Stock BioHarvest Sciences Inc. - Canadian Securities Exchange